HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

You-Cheng Hseu Selected Research

Cytochromes c (Cytochrome c)

12/2014Induction of macrophage cell-cycle arrest and apoptosis by humic acid.
4/2014The anti-tumor activity of Antrodia salmonea in human promyelocytic leukemia (HL-60) cells is mediated via the induction of G₁ cell-cycle arrest and apoptosis in vitro or in vivo.
3/2012The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway.
1/2012The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways.
1/2012Inhibition of Cell Growth and Induction of Apoptosis by Antrodia camphorata in HER-2/neu-Overexpressing Breast Cancer Cells through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


You-Cheng Hseu Research Topics

Disease

25Neoplasms (Cancer)
12/2021 - 08/2008
13Inflammation (Inflammations)
01/2022 - 12/2010
13Neoplasm Metastasis (Metastasis)
12/2021 - 04/2012
10Melanoma (Melanoma, Malignant)
01/2022 - 01/2012
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2012
7Carcinoma (Carcinomatosis)
09/2021 - 03/2012
7Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 01/2012
7Hemolysis
10/2017 - 06/2002
7Atherosclerosis
08/2017 - 01/2006
5Carcinogenesis
01/2022 - 09/2012
5Leukemia
01/2018 - 08/2004
4Triple Negative Breast Neoplasms
12/2021 - 01/2017
4Necrosis
09/2021 - 08/2010
4Colonic Neoplasms (Colon Cancer)
01/2021 - 02/2011
4Breast Neoplasms (Breast Cancer)
05/2019 - 07/2007
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 01/2019
3Lung Neoplasms (Lung Cancer)
03/2019 - 02/2010
3Wounds and Injuries (Trauma)
02/2019 - 01/2012
3Mouth Neoplasms (Oral Cancer)
09/2012 - 03/2012
2Glioblastoma (Glioblastoma Multiforme)
09/2021 - 03/2019
2Fibrosis (Cirrhosis)
01/2019 - 01/2010
2Prostatic Neoplasms (Prostate Cancer)
12/2018 - 09/2014
2Edema (Dropsy)
12/2014 - 12/2010
2Infections
10/2014 - 07/2011
2Squamous Cell Carcinoma of Head and Neck
09/2012 - 08/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2012 - 06/2011
1Colitis
01/2021
1Pancreatitis
01/2020

Drug/Important Bio-Agent (IBA)

14AntioxidantsIBA
01/2021 - 01/2006
11Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2002
11Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 12/2006
9Caspase 3 (Caspase-3)IBA
01/2021 - 01/2012
7flavokawain BIBA
01/2021 - 03/2012
7Chalcone (Benzalacetophenone)IBA
01/2021 - 03/2012
72,2'-azobis(2-amidinopropane) (ABAP)IBA
10/2017 - 06/2002
6Coenzymes (Enzyme Cofactors)IBA
09/2021 - 02/2016
6CateninsIBA
05/2019 - 01/2012
5quinone (benzoquinone)IBA
01/2022 - 02/2016
5Cytochromes c (Cytochrome c)IBA
12/2014 - 01/2012
4Melanins (Melanin)IBA
01/2022 - 01/2015
4Annexin A5IBA
09/2021 - 08/2012
4DNA (Deoxyribonucleic Acid)IBA
09/2020 - 02/2010
4Free RadicalsIBA
10/2017 - 09/2011
4Gallic AcidIBA
05/2013 - 01/2008
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 01/2019
3Cadherins (E-Cadherin)IBA
05/2019 - 01/2019
3naringeninIBA
03/2019 - 09/2014
3Small Interfering RNA (siRNA)IBA
01/2019 - 02/2011
3ChalconesIBA
01/2019 - 03/2012
3LipidsIBA
10/2017 - 06/2002
3Humic SubstancesIBA
12/2014 - 08/2004
3Caspase 9IBA
12/2014 - 01/2012
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2thiazolyl blueIBA
01/2021 - 01/2019
2Monophenol Monooxygenase (Tyrosinase)IBA
01/2020 - 01/2019
2LipopolysaccharidesIBA
01/2020 - 01/2015
2LuciferasesIBA
05/2019 - 02/2019
2Fas Ligand Protein (Fas Ligand)IBA
01/2019 - 04/2014
2lucidoneIBA
01/2017 - 09/2013
2Estrogen ReceptorsIBA
01/2017 - 01/2012
2Pharmaceutical PreparationsIBA
09/2014 - 07/2007
2Cyclin AIBA
04/2014 - 03/2012
2Cyclin D1IBA
04/2014 - 08/2008
2LDL Lipoproteins (beta Lipoproteins)IBA
04/2014 - 01/2010
2SOXC Transcription FactorsIBA
01/2013 - 01/2012
2perhydroxyl radicalIBA
09/2006 - 06/2002
17,3'-dihydroxy-4'-methoxyisoflavoneIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1G-Protein-Coupled Receptor Kinase 3IBA
01/2022
1bisdemethoxycurcuminIBA
12/2021
1Twist-Related Protein 1IBA
12/2021
1Metalloproteases (Metalloproteinases)IBA
12/2021
1TOR Serine-Threonine KinasesIBA
12/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2021
1Sirolimus (Rapamycin)FDA Link
12/2021
1SodiumIBA
01/2021
1Dextrans (Dextran)FDA Link
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1AzoxymethaneIBA
01/2021
1Melanocyte-Stimulating Hormones (MSH)IBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
10/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2020
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2020
1Intercalating AgentsIBA
09/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2020
1Conditioned Culture MediaIBA
01/2020
1ectoineIBA
01/2020
1tyrosinase-related protein-1IBA
01/2020
1Cyclic AMP (AMP, Cyclic)IBA
01/2020
1Adenosine Monophosphate (AMP)IBA
01/2020
1Carrier Proteins (Binding Protein)IBA
01/2020
1Protein Kinase CIBA
01/2020
1Microphthalmia-Associated Transcription FactorIBA
01/2020
1flavokawain AIBA
01/2020
1Lipase (Acid Lipase)FDA Link
01/2020
1Cholecystokinin (Pancreozymin)IBA
01/2020
1Hematoxylin (Haematoxylon)IBA
05/2019
1Eosine Yellowish-(YS) (Eosin)IBA
05/2019
1Ethanol (Ethyl Alcohol)IBA
02/2019

Therapy/Procedure

1Therapeutics
12/2021